A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Clinical trial NCT03892889 · TERMINATED
Trial details
- NCT number
- NCT03892889
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2020-08-12
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.